BioPharma Resources

Drug Trial Radar · NCT03235024

Study to Determine Safety and Efficacy of B244 in Subjects With Mild to Moderate Atopic Dermatitis

A Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized, Phase II Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Mild to Moderate Atopic Dermatitis

Last checked: Nov 19, 2026Latest source record: Oct 10, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 122 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

122

Actual

Start

Jan 15, 2018

Primary completion

Feb 27, 2019

Study completion Mar 20, 2019

Sponsor

Lead sponsor
AOBiome LLCIndustry
Sponsor type
Industry
Collaborators
Veristat, Inc.
First posted
Aug 1, 2017

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Prospective, Vehicle Controlled, Double Blind, Multicenter, Randomized Phase II trial, comparing the effect of twice daily B244 application for 28 days vs vehicle application on treatment of mild to moderate AD

Conditions

  • Atopic Dermatitis Eczema

Interventions

  • B244Biological

    B244 suspension

  • VehicleBiological

    Vehicle suspension

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0Time frame: Baseline to Day 42

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Central Research Associates

    Birmingham, Alabama

  • Elite Clinical Studies

    Phoenix, Arizona

  • Encino Research Center

    Encino, California

  • Orange County Research Center

    Tustin, California

  • Neostart Corporation d.b.a AGA Clinical Trials

    Hialeah, Florida

  • Clinical Neuroscience Solution, Inc

    Jacksonville, Florida

  • FXM Research Corp.

    Miami, Florida

  • FXM Research Miramar

    Miramar, Florida

  • Clinical Neuroscience Solution, Inc

    Orlando, Florida

  • Clinical Research Trials of Florida, Inc.

    Tampa, Florida

  • Columbus Regional Research Institute

    Columbus, Georgia

  • DeNova Research dba Arano, LLC

    Chicago, Illinois

  • Clarkston Skin Research

    Clarkston, Michigan

  • MediSearch Clinical Trials

    Saint Joseph, Missouri

  • LoveLace Scientific Resources

    Albuquerque, New Mexico

  • Central Sooner Research

    Norman, Oklahoma

  • Paddington Testing Co.

    Philadelphia, Pennsylvania

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.